News

Stay informed about Enzene Biosciences, keep up with the latest news and stay at the forefront of industry advancements.

Enzene Receives EU GMP Certification for its Facilities in India

Enzene Receives EU GMP Certification for its Facilities in India

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that its two facilit [...]

Learn more
Enzene Biosciences launches biosimilar Ranibizumab

Enzene Biosciences launches biosimilar Ranibizumab

Enzene Biosciences has now launched Ranibizumab, a biosimilar to innovator product Lucentis® that is sold under the bran [...]

Learn more
Enzene Biosciences launches biosimilar Adalimumab

Enzene Biosciences launches biosimilar Adalimumab

Enzene Biosciences Ltd. has announced that it has begun commercial supplies of Adalimumab for treating Ankylosis Spondyl [...]

Learn more
Enzene Biosciences launches Bevacizumab

Enzene Biosciences launches Bevacizumab

Enzene Biosciences has now announced the India launch of Bevacizumab, a biosimilar of Avastin® that is used for the trea [...]

Learn more
Enzene Biosciences launches Cetuximab

Enzene Biosciences launches Cetuximab

Enzene Biosciences has launched Cetuximab as the first biosimilar treatment option for a wide range of ailments like can [...]

Learn more
Enzene Biosciences unveils cutting-edge 75,000 sq. ft R&D facility in Pune

Enzene Biosciences unveils cutting-edge 75,000 sq. ft R&D facility in Pune

Enzene announces inauguration of new state-of-the-art research and development facility in Pune

Learn more
Enzene launches Discovery Services division at BIO 2024

Enzene launches Discovery Services division at BIO 2024

Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (Enze [...]

Learn more
Enzene Biosciences launches its first manufacturing base in the US, at its New Jersey site

Enzene Biosciences launches its first manufacturing base in the US, at its New Jersey site

The 54,000 square feet New Jersey plant can cater to future expansion plans and establishes Enzene Inc. as a premier glo [...]

Learn more
Enzene Launches  EnzeneX™ 2.0

Enzene Launches EnzeneX™ 2.0

Enzene Launches EnzeneX™ 2.0: The Next Generation of its Fully-Connected Continuous Manufacturing™ (FCCM™) Technology fo [...]

Learn more
Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Enzene appoints Norm Stoffregen as SVP, site head at Enzene's new $50M manufacturing facility in New Jersey

Learn more
ADVANZ PHARMA and Enzene enter an exclusive partnership for biosimilar development and commercialisation

ADVANZ PHARMA and Enzene enter an exclusive partnership for biosimilar development and commercialisation

ADVANZ PHARMA Holdco Limited and Enzene Biosciences today announced a strategic partnership for the commercialisation of [...]

Learn more
Enzene Biosciences launches its first manufacturing base in the US

Enzene Biosciences launches its first manufacturing base in the US

The company has leased 54,000 square feet of space to host multiple manufacturing lines of its continuous manufacturing [...]

Learn more
Enzene obtains Marketing Authorization for its first Biosimilar molecule in India

Enzene obtains Marketing Authorization for its first Biosimilar molecule in India

Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller Genera [...]

Learn more
Enzene Opens its First Continuous Biologics Manufacturing Facility

Enzene Opens its First Continuous Biologics Manufacturing Facility

Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, [...]

Learn more